CoQ-10 treats diabetic neuropathy

CoQ-10 treats diabetic neuropathy


(NaturalNews) The marvels of CoQ-10 continue to be discovered by actual
mainstream medical research. Of course, this type of research doesn't
get the media hype that Big Pharma's "miracle medicines" do. Thank
goodness for the internet.

Two separate, recent studies on CoQ-10
were logged into medical journals, one in the U.S. and the other in
Iran. The Iranian study was undertaken to determine the possibility of
increasing male fertility among those who are infertile. The U.S. study
in Miami, Florida demonstrated reduction of diabetic induced neuropathy.

Coenzyme Q10 or CoQ-10 briefly explained

CoQ-10
or coenzyme Q10 is a coenzyme that supports enzyme activity, which is
vital to proper cellular metabolism within the cell's mitochondria
throughout the body. Proper metabolism also makes efficient use of
oxygen, thus CoQ-10 is also considered an antioxidant that inhibits free
radicals forming from cellular metabolism.

Mitochondria are the
cells energy factories, creating adenosine triphosphate (ATP), which are
the essential energy storage molecules of animal and human life.
Respiration, or the utilization of oxygen, is the key to this process.

According
to Dr. Andrew Weil, daily doses of up to 1200 mg can be supplemented
safely. Although it appears throughout the body, certain high energy
organs, such as the heart, require more. Coenzyme Q10 manifests as
ubiquinone or ubiquinol.

Ubiquinone is the oxidized version of
CoQ-10 that appears all throughout the body and can be partially
converted to an active antioxidant form. That's why CoQ-10 ubiquinol
supplements are more potent and require smaller dosage but at a higher
price. They're ready to go without conversion.

By the way, statin drugs inhibit the body's production of CoQ-10.

Two recent CoQ-10 studies

At the University of Miami Miller School of Medicine,
56 subject mice were chemically induced with diabetes while 20 other
normal mice were isolated for control purposes. Poor subject mice.

The subject mice were treated to low doses of CoQ10.
Behavioral observation was used partially to determine pain levels
while several serum and biochemical analyses were used to determine
CoQ-10 activity.

The subject mice had some weight loss without lower glucose levels while the control mice weights remained constant.

Long-term
low dose CoQ-10 inhibited neuropathy induced pain. From the study's
notes: "Dorsal root ganglia, sciatic nerve, and spinal cord tissues from
diabetic mice
demonstrated increased lipid peroxidation that was reduced by CoQ10
treatment. CoQ10 administration was also noted to reduce the
pro-inflammatory factors in the peripheral and central nervous system."

The study concluded that, "CoQ10 administration may represent a low-risk, high-reward strategy for preventing or treating diabetic neuropathy."
This begs the question: What about other sources of neuropathy
resulting from excess antibiotic use, vaccinations, or statin drugs?
More studies, perhaps.

But it appears to this author that trying
out CoQ-10 is a low risk endeavor for reducing nervous system
inflammation manifesting as neuropathy from any source.

The Iranian study focused on coenzyme Q10 for treating male infertility. The reason the researchers at Shahid Sadoughi University of Medical Sciences, undertook the study is that prior research had already determined that infertile men had low levels of CoQ-10 in their semen.

So
why not try giving some of these guys some CoQ-10 supplements to see
what happens? They chose 60 infertile men and divided them into CoQ-10
and placebo groups. The subject group was treated to 200 mg CoQ-10, not
really much, for three months while the placebo group did without. Too
bad placebo people, you were duped.

Anyway, seminal biological
markers for the subject group were significantly improved over the
placebo control group. The researchers concluded that three months of
CoQ-10 for "... infertile men can attenuate oxidative stress in seminal
plasma and improve semen parameters and antioxidant enzymes activity."
Maybe phase two of this study should be done at least a year later?

Source:-
http://www.naturalnews.com/039412_CoQ10_diabetic_neuropathy_medical_research.html